Ohashi Naro, Takase Hiroyuki, Aoki Taro, Ishigaki Sayaka, Iwakura Takamasa, Isobe Shinsuke, Fujikura Tomoyuki, Kato Akihiko, Yasuda Hideo
Internal Medicine 1, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Department of Internal Medicine, Enshu Hospital, 1-1-1 Chuo, Naka-ku, Hamamatsu, 430-0929, Japan.
Hypertens Res. 2022 Jun;45(6):944-953. doi: 10.1038/s41440-022-00914-3. Epub 2022 Apr 14.
Excessive salt intake causes hypertension and heart diseases. B-type natriuretic peptide (BNP) is a surrogate marker of heart disease, and a slightly elevated BNP level is associated with a poor prognosis. Our previous cross-sectional study demonstrated that plasma BNP has a significant positive association with daily salt intake in the general population. However, the relationship between changes in salt intake and changes in plasma BNP remains unknown. We recruited 3051 participants without hypertension or electrocardiogram abnormalities who underwent annual health check-ups for two consecutive years. Clinical parameters, including plasma BNP, were obtained, and daily salt intake was evaluated using urinary samples. Annual changes in these parameters were calculated. The median plasma BNP level was 12.9 pg/mL, and the daily salt intake was 8.73 ± 1.89 g. The annual changes in plasma BNP and daily salt intake were 4.79 ± 36.38% and 2.01 ± 21.80%, respectively. Participants in the highest quartile of annual changes in daily salt intake showed the largest annual changes in plasma BNP. Annual changes in plasma BNP indicated a significant positive association with daily salt intake. Moreover, multiple linear regression analyses revealed that annual changes in plasma BNP showed a significant positive association with daily salt intake after adjustments. Our study showed a significant positive relationship between annual changes in plasma BNP and annual changes in daily salt intake. The suppression of plasma BNP is therefore induced by salt intake restriction. The monitoring of plasma BNP while reducing salt intake may therefore prevent heart diseases and lead to improved prognoses in the general population without heart diseases.
过量摄入盐会导致高血压和心脏病。B型利钠肽(BNP)是心脏病的替代标志物,BNP水平略有升高与预后不良相关。我们之前的横断面研究表明,普通人群血浆BNP与每日盐摄入量呈显著正相关。然而,盐摄入量变化与血浆BNP变化之间的关系尚不清楚。我们招募了3051名无高血压或心电图异常的参与者,他们连续两年接受年度健康检查。获取了包括血浆BNP在内的临床参数,并使用尿样评估每日盐摄入量。计算这些参数的年度变化。血浆BNP水平中位数为12.9 pg/mL,每日盐摄入量为8.73±1.89 g。血浆BNP和每日盐摄入量的年度变化分别为4.79±36.38%和2.01±21.80%。每日盐摄入量年度变化最高四分位数的参与者血浆BNP年度变化最大。血浆BNP的年度变化表明与每日盐摄入量呈显著正相关。此外,多元线性回归分析显示,调整后血浆BNP的年度变化与每日盐摄入量呈显著正相关。我们的研究表明,血浆BNP的年度变化与每日盐摄入量的年度变化之间存在显著正相关。因此,限制盐摄入可诱导血浆BNP降低。因此,在减少盐摄入的同时监测血浆BNP可能预防心脏病,并改善无心脏病普通人群的预后。